References
Jundt F, Probsting KS, Anagnostopoulos I, Muehlinghaus G, Chatterjee M, Mathas S et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood 2004; 103: 3511–3515.
Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B . Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 2002; 99: 3398–3403.
Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI . Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood 2004; 103: 3503–3510.
Houde C, Li Y, Song L, Barton K, Zhang Q, Godwin J et al. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 2004; 104: 3697–3704.
Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI . Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008; 111: 2220–2229.
Terpos E, Sezer O, Croucher P, Dimopoulos MA . Myeloma bone disease and proteasome inhibition therapies. Blood 2007; 110: 1098–1104.
Zavrski I, Krebbel H, Wildemann B, Heider U, Kaiser M, Possinger K et al. Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function. Biochem Biophys Res Commun 2005; 333: 200–205.
Robey PG, Termine JD . Human bone cells in vitro. Calcif Tissue Int 1985; 37: 453–460.
Acknowledgements
We thank Katharina Kley for excellent technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft Klinische Forschergruppe KFO 105 (UH, OS, BD, FJ) and SFB 449 (RP), and from the Deutsche Krebshilfe 10-6930 (RP).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schwarzer, R., Kaiser, M., Acikgoez, O. et al. Notch inhibition blocks multiple myeloma cell-induced osteoclast activation. Leukemia 22, 2273–2277 (2008). https://doi.org/10.1038/leu.2008.138
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.138
- Springer Nature Limited
This article is cited by
-
Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival
Blood Cancer Journal (2023)
-
Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model
Blood Cancer Journal (2014)
-
Fact or fiction - identifying the elusive multiple myeloma stem cell
Journal of Hematology & Oncology (2013)
-
Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes
Leukemia (2013)
-
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1
Leukemia (2013)